CClinicalTrials.gg
CompletedNCT02710942Updated Oct 16, 2018

Testing myWHI: Online Self-guided Programs for Migraine

An interventional study of SPHERE and PRISM in Migraine Headache, sponsored by IWK Health Centre. Completed at 1 site in Canada. Open to participants aged 14 Years to 35 Years. Per ClinicalTrials.gov, last updated 2018-10-16.

Sponsored by IWK Health Centre · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
14 Years to 35 Years
Sex
All
01

Study summary

The goal for this pilot study is to assess the acceptability of two online self-guided programs for migraines. The programs are part of the investigators' collection of "my Wireless Headache Interventions" (myWHI). The Specialized Program for Headache Reduction (SPHERE) is a program that teaches cognitive and behavioural skills/techniques to help manage headaches. The PeRsonalized Intervention for Self-Management of Migraine (PRISM) helps users to discover their headache triggers and provides recommendations for managing them. This pilot will also assess the feasibility of the study protocol to inform a full scale randomized controlled trial (RCT).

02

Conditions studied

  • Migraine Headache
03

In context

Migraine Disorders

1,528 studies on the registry are indexed under Migraine Disorders; 299 are open to participants now.

This study's enrollment of 60 is below the median of 80 across 1,175 interventional studies indexed under Migraine Disorders.

Browse Migraine Disorders studies →

Lead sponsor

IWK Health Centre is the lead sponsor of 83 studies on the registry; 17 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
14 Years to 35 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • aged 14-35 years
  • fluent in the English language (i.e., speaking, reading and writing);
  • suffer from headaches for a minimum of one year
  • stable pattern of headache symptoms (e.g., headache frequency, severity, location of pain, symptoms associated with headache) for the past 6 months
  • suffer from migraine headaches as indicated with a score of 2 and above on the ID Migraine
  • use the Smartphone for activities other than texting and calling (e.g., email, Facebook)
  • have daily Internet access from their Smartphone
  • minimum of four headache days during 4 weeks of using an electronic headache diary

Exclusion criteria

Exclusion Criteria:

  • health care professional has not ruled out any underlying medical condition related to their headaches (e.g., head trauma, meningitis)
  • are pregnant, planning to get pregnant (in the next 4 to 6 months), or breastfeeding
  • have an impairment which compromises their ability to give informed consent
  • having been diagnosed with psychosis and/or schizophrenia
  • they complete less than 50% of daily entries (i.e., less than 14 daily entries) in an electronic headache dairy
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    SPHERE intervention

    It is a comprehensive self-guided Internet-based cognitive-behavioral therapy (CBT) that includes three components: (1) the myWHI diary. (2) 30 multi-media learning topics that the user is encouraged to go through in a sequential way. The topics contain education information and teach strategies to cope better with their headaches.

    Behavioral: SPHERE

  • Experimental
    PRISM intervention

    It is a targeted self-guided Internet-based CBT intervention. PRISM was built upon the myWHI diary, an electronic headache diary. PRISM helps users discover their headache triggers by analyzing the inputted diary data using association rule mining. Once one or multiple headache triggers are identified the application uses an algorithm to provide the user with a few personalized recommendations to help them to cope with these triggers. The algorithm is based on the opinion of clinical experts (e.g., medical health professionals, psychologists). The user chooses recommendations to follow and sets goals in the application to follow them. To support the process, the application checks in with users about their goals and tracks goal completion.

    Behavioral: PRISM

  • No intervention
    Usual care

    Participants can continue doing what they usually do to deal with their migraines.

Interventions

  • BehavioralSPHERE
  • BehavioralPRISM
06

What researchers measure

Primary outcomes

  1. Average number of individuals who complete the online screening per month

    This is an exploratory study and we do not know how much time it will take for us to recruit our desired sample size. However, our maximum time frame is 1 year.

    Time frame: After reaching our desired sample size for randomization

  2. Proportion of recruited participants who are eligible for study entry

    This is an exploratory study and we do not know how much time it will take for us to recruit our desired sample size. However, our maximum time frame is 1 year.

    Time frame: After reaching our desired sample size for randomization

  3. Proportion of eligible participants who consent

    This is an exploratory study and we do not know how much time it will take for us to recruit our desired sample size. However, our maximum time frame is 1 year.

    Time frame: After reaching our desired sample size for randomization

  4. Proportion of consented participants who are randomized

    This is an exploratory study and we do not know how much time it will take for us to recruit our desired sample size. However, our maximum time frame is 1 year.

    Time frame: After reaching our desired sample size for randomization

  5. Proportion of randomized participants who drop out

    Time frame: At 4-month post-randomization

  6. Level of usage of the Internet-based interventions (i.e., PRISM and SPHERE). Intervention usage will be tracked automatically

    Time frame: At 4-month post-randomization

  7. Proportion of consented participants who complete the baseline assessment

    This is an exploratory study and we do not know how much time it will take for us to recruit our desired sample size. However, our maximum time frame is 1 year.

    Time frame: After reaching our desired sample size for randomization

  8. Proportion of randomized participants who complete the 4-month post-randomization assessment

    Time frame: At 4-month post-randomization

  9. Acceptability of the Internet-based interventions (i.e., PRISM and SPHERE) using the 8-item Client Satisfaction Questionnaire (CSQ-8)

    Time frame: At 4-mont post-randomization

  10. Acceptability of the Internet-based interventions (i.e., PRISM and SPHERE) using the single-item Patients' Global Impression of Change Scale (PGIC)

    Time frame: At 4-mont post-randomization

  11. Acceptability of the Internet-based interventions (i.e., PRISM and SPHERE) using the satisfaction interviews

    Time frame: At 4-mont post-randomization

  12. Proportion of participants in the control group who show clinically significant improvement (50% or greater reduction) from baseline in number of headache days in the last 4 weeks

    Time frame: At 4-mont post-randomization

07

Study locations

1 site
  • IWK Health Centre
    Halifax, Nova Scotia B3K 6R8, Canada
08

References and documents

Related links

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 16, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02710942
Lead sponsor
IWK Health Centre
Responsible party
Anna Huguet (Research Scientist, IWK Health Centre) — Principal investigator
First posted
Mar 17, 2016
Start date
Feb 2016
Primary completion
Jul 2016
Completion
Dec 2016
Last update
Oct 16, 2018

Study contacts

Anna Huguet, PhD
principal investigator · IWK Health Centre

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion